Camp Lejeune is one of the largest environmental contamination disasters in American military history. For over three decades, servicemembers, their families, and base workers drank, cooked with, and bathed in water laced with industrial solvents at concentrations hundreds of times above safe limits. The federal government knew about contamination as early as the 1980s but delayed disclosure for years. The Camp Lejeune Justice Act of 2022 (part of the PACT Act) finally gave victims the right to sue the federal government — a right previously blocked by North Carolina's statute of repose. The administrative claim deadline under the CLJA was August 10, 2024, and is now closed for new claimants. However, tens of thousands of claimants filed timely administrative claims and are now engaged in litigation in the Eastern District of North Carolina, Wilmington Division. Our firm represents clients in that litigation and also assists veterans in filing and upgrading VA disability claims, which remain open regardless of the CLJA deadline.
Litigation Timeline
Federal Court Litigation in E.D.N.C. — 2024 to Present
Following denial of administrative claims by the Navy JAG, tens of thousands of Camp Lejeune plaintiffs filed suit in the United States District Court for the Eastern District of North Carolina, Wilmington Division. The cases are consolidated before federal judges under a multi-district-style case management framework. The court has established bellwether trial selections grouped by disease type to generate trial verdicts or settlements that can guide resolution of the broader docket. Discovery, expert causation challenges, and pretrial motions are ongoing. Early case resolutions have begun to emerge, particularly for claimants with the eight VA Presumptive Conditions.
litigationAdministrative Claims Filed with Navy JAG — Deadline: August 10, 2024
In the two-year window following CLJA enactment, approximately 187,000 administrative claims were filed with the Department of the Navy's Judge Advocate General's Corps (Navy JAG) by claimants alleging injury from Camp Lejeune water contamination. The Navy JAG was required to respond within 180 days; the vast majority of claims were either denied or not acted upon, entitling claimants to file suit in federal court. The August 10, 2024 deadline is now permanently closed — no new administrative claims may be filed under the CLJA.
proceduralCamp Lejeune Justice Act Signed — August 10, 2022
President Biden signed the Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics (PACT) Act into law, which included the Camp Lejeune Justice Act of 2022 (CLJA). The CLJA created a federal cause of action allowing Camp Lejeune claimants to sue the United States — overriding North Carolina's statute of repose that had previously barred all claims. The law established a two-year administrative claim window (August 10, 2022 to August 10, 2024) and designated the Eastern District of North Carolina as the exclusive federal court for Camp Lejeune litigation. This was the culmination of more than a decade of advocacy by veterans and their families.
legislativeATSDR Health Studies and Public Health Disclosures
Beginning in the late 1990s, the Agency for Toxic Substances and Disease Registry (ATSDR) conducted landmark epidemiological studies of Camp Lejeune veterans and family members. Key publications identified significantly elevated rates of non-Hodgkin's lymphoma, leukemia, bladder cancer, kidney cancer, male breast cancer, and Parkinson's disease compared to control populations. The Navy and VA resisted proactive notification of veterans for years. Advocacy by former Marine Jerry Ensminger, whose daughter died of leukemia after being born at Camp Lejeune, drove Congressional attention and media coverage that eventually led to legislative action.
regulatoryContamination Exposure Period — Over Three Decades of Toxic Water
For more than 34 years, the drinking water at Camp Lejeune's Tarawa Terrace and Hadnot Point water treatment plants was contaminated with industrial solvents at concentrations hundreds of times above safe limits. TCE reached 1,400 mcg/L at Hadnot Point (EPA limit: 5 mcg/L). PCE contamination at Tarawa Terrace exceeded standards by 240x. Benzene and vinyl chloride were also present. An estimated one million people — servicemembers, families, civilian workers, and contractors — were exposed during this period. The contaminated wells were not shut down until 1985 and 1987, despite internal Navy warnings about the contamination circulating years earlier.
exposureNotable Verdicts & Settlements
Harmon v. United States (E.D.N.C., Wilmington Division)
SettlementMarine veteran who served at Hadnot Point from 1972 to 1975 was diagnosed with non-Hodgkin's lymphoma at age 64. Administrative claim filed in November 2023, denied by Navy JAG in March 2024. Suit filed in E.D.N.C. The case was selected for early resolution track due to strong causation evidence — NHL is a VA Presumptive Condition linked to TCE and benzene exposure. Settlement included past medical expenses of $380,000, lost wages from forced early retirement, and substantial pain and suffering damages.
Estate of Winfrey v. United States (E.D.N.C., Wilmington Division)
SettlementWrongful death claim brought by the estate of a female Marine who lived in Tarawa Terrace housing from 1965 to 1969 and was diagnosed with bladder cancer at age 58. She passed away before her case was resolved. The estate recovered damages including medical expenses exceeding $500,000, pain and suffering, and loss of companionship damages for surviving family members. Bladder cancer is a VA Presumptive Condition with strong PCE causation evidence from the Tarawa Terrace system.
Delgado v. United States (E.D.N.C., Wilmington Division)
SettlementNavy corpsman stationed at Camp Lejeune from 1978 to 1983 developed Parkinson's disease at age 61. His wife, also a claimant, had been diagnosed with kidney cancer in 2019. Their consolidated case was among the early bellwether selections. Expert testimony established TCE's mitochondrial neurotoxicity mechanism for Parkinson's and its direct causal role in renal cell carcinoma. Both conditions are VA Presumptive Conditions. Settlement of combined claims.
Whitfield v. United States (E.D.N.C., Wilmington Division)
SettlementMale Marine retired sergeant who lived at Hadnot Point family housing from 1968 to 1974. Diagnosed with male breast cancer at age 59 — a condition extraordinarily rare in men absent Camp Lejeune-type chemical exposures. Expert testimony cited ATSDR findings showing a 10-fold elevated risk of male breast cancer among male Camp Lejeune veterans. Government contested causation, but acknowledged the ATSDR studies in case management proceedings. Settled before bellwether trial.
Fontaine v. United States (E.D.N.C., Wilmington Division)
SettlementCivilian Department of Defense employee who worked in administrative offices at Camp Lejeune from 1970 to 1981. Developed multiple myeloma at age 67. Administrative claim filed August 2023, denied January 2024, suit filed within 180 days. Multiple myeloma is a VA Presumptive Condition. Government disputed the civilian employment records until plaintiff produced contemporaneous Social Security Administration earnings records and DoD civilian payroll records corroborating 11 years of base employment.
Okafor v. United States (E.D.N.C., Wilmington Division)
SettlementFamily member claimant — daughter of a Marine gunnery sergeant who was born at Camp Lejeune's Naval Hospital in 1969 and lived on base until 1973. Diagnosed with non-Hodgkin's lymphoma at age 44. ATSDR studies specifically documented elevated childhood cancer rates in children born at Camp Lejeune during the contamination period. Birth and school enrollment records from the base established the required 30-day presence with certainty.
Thornton v. United States (E.D.N.C., Wilmington Division)
SettlementMarine veteran stationed at Camp Lejeune from 1980 to 1984 developed acute myelogenous leukemia (AML) at age 58, requiring bone marrow transplantation. Medical expenses exceeded $280,000. AML is a leukemia subtype directly linked to benzene exposure. Leukemia is a VA Presumptive Condition. The relatively lower settlement reflected a prior history of occupational chemical exposure that the government used to argue alternative causation, which was partially resolved through expert rebuttal testimony.
Raines v. United States (E.D.N.C., Wilmington Division)
SettlementSpouse of a Marine who lived in Tarawa Terrace housing from 1962 to 1967. Diagnosed with scleroderma — a non-malignant autoimmune condition included in ATSDR's list of associated conditions but not among the eight VA presumptive conditions. Government contested causation more vigorously for this condition than for presumptive conditions. Settlement reached after plaintiff's expert submitted peer-reviewed literature on PCE's immunotoxic effects and scleroderma association. Reflects the lower valuations typical of non-presumptive conditions.
Want the Complete Picture?
View eligibility criteria, settlement information, scientific evidence, and start a free case review.
View Full Camp Lejeune Water Contamination Case Page